Who to call at VERAXA Biotech, and when
Fundz watches for the moments VERAXA Biotech starts buying, and tells you who to reach.
- An alert the day VERAXA Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VERAXA Biotech, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
VERAXA Biotech Forms Partnership with ATUM for Cell Line Development of BiTAC® T-Cell Engager Program.
Jul 09, 2026
Contract Type
partnership
ZurichBiotechnologyHealth CareDescription
VERAXA Biotech has partnered with ATUM to develop stable clonal cell lines for its BiTAC(R) T-cell engager program. This collaboration marks a significant milestone in advancing their candidate toward IND/CTA-enabling studies and improving the selectivity of T-cell engagers.
Related People
Agreement Insights
What this usually meansStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
VERAXA Biotech signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.